https://scholars.lib.ntu.edu.tw/handle/123456789/621248
Title: | Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis | Authors: | Blauvelt, Andrew TSEN-FANG TSAI Langley, Richard G Miller, Megan Shen, Yaung-Kaung You, Yin Yang, Ya-Wen Papp, Kim A Puig, Luis |
Keywords: | adverse events; biologics; guselkumab; infections; malignancy; psoriasis; safety | Issue Date: | 2022 | Publisher: | MOSBY-ELSEVIER | Journal Volume: | 86 | Journal Issue: | 4 | Start page/Pages: | 827 | Source: | Journal of the American Academy of Dermatology | Abstract: | Guselkumab effectively treats moderate-to-severe psoriasis. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/621248 | ISSN: | 0190-9622 | DOI: | 10.1016/j.jaad.2021.11.004 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.